{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-26-003077","form_type":"8-K","ticker":"TOMZ","cik":"0000314227","company_name":"TOMI Environmental Solutions, Inc.","filed_at":"2026-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.342322+00:00","generated_at":"2026-05-15T08:17:34.016932+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"TOMI full-year 2025 revenue falls 27% to $5.6M; net loss narrows to $0.19/shr","bullets":["Net sales $5.636M vs $7.739M in 2024; customers deferred capex due to tariffs and Middle East crisis.","Net loss $(3.749M) or $(0.19) per share vs $(4.477M) or $(0.22) per share in 2024.","Cash and equivalents $88,000; working capital $1.0M; accumulated deficit $58.1M.","International revenue grew to 29% of total (from 21%); sales backlog increased to ~$1.8M.","Integration project pipeline ~$3M; ELOC up to $20M with first draw of $94,130 in Feb 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-003077","json":"https://secwatch.observer/filing/0001654954-26-003077.json","markdown":"https://secwatch.observer/filing/0001654954-26-003077.md","text":"https://secwatch.observer/filing/0001654954-26-003077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/314227/000165495426003077/0001654954-26-003077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/314227/000165495426003077/tomz_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:17:34.016932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"98be54669d35cff41e52c16b86aa0e175e57539b","claim":"TOMI Environmental Solutions, Inc. reported the year ended December 31, 2025 results: revenue $5,636,000, net income $(3,749,000), EPS ($0.19) per basic and diluted share.","evidence_excerpt":"deformed wing virus (DWV) for agricultural biosecurity in honeybees. Financial Results for the year ended December 31, 2025, compared to December 31, 2024 · Sales, net was $5,636,000 compared to $7,739,000 for the years ended December 31, 2025 and 2024, respectively. This was primarily driven by customers deferring capital expenditure projects due to the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/314227/000165495426003077/0001654954-26-003077-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2025"},{"label":"Revenue","value":"$5,636,000"},{"label":"Net income","value":"$(3,749,000)"},{"label":"EPS","value":"($0.19) per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}